Effects of methotrexate and etanercept treatment in moderate and severe psoriasis.

[ 6 ] In 2018, a study conducted by the Ecuadorian Psoriasis Foundation determined that approximate 0.59% of the country’s population suffers from this condition, in addition to a marked trend toward an increase in cases; currently, there are approximately 100,000 Ecuadorians diagnosed with psoriasis, with a predilection for male patients, between 40 and 60 years of age.

also in 422 other papers

Student’s t test was used the etanercept and methotrexate treatment in the PASI evolution in the initial phase and at the end of the control phase was lower 0.001 < P = .05 demonstrating a highly significant response, previously referred to in the PASI evaluation, where the scaly and erythematous lesions had an excellent response to this type of biological treatment (Table 4 ).

also in 132,142 other papers